A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis.
Artículo
en Inglés
| IMSEAR
| ID: sea-65783
ABSTRACT
BACKGROUND:
Kamalahar is an indigenous preparation reported to be beneficial in acute viral hepatitis.AIMS:
To evaluate the efficacy of Kamalahain acute viral hepatitis in a double-blind, placebo-controlled study.METHODS:
Fifty two patients with acute viral hepatitis were randomized to receive either Kamalahar 500 mg or a matched placebo three times a day for 15 days. Forty four patients (Kamalahar 20; placebo 24) completed the trial.RESULTS:
Improvement in clinical signs was more marked with Kamalahar compared to placebo. The fall in serum bilirubin (p < 0.001), SGPT (p < 0.001) and serum alkaline phosphatase (p < 0.005) at day 15 was significantly greater with the drug. No significant side effects were observed.CONCLUSION:
Kamalahar offers therapeutic promise in acute viral hepatitis.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Femenino
/
Humanos
/
Masculino
/
Extractos Vegetales
/
Método Doble Ciego
/
Enfermedad Aguda
/
Adolescente
/
Adulto
/
Hepatitis Viral Humana
/
Medicina Ayurvédica
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Año:
1993
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS